早产/低出生体重儿喂养建议

早产/低出生体重儿是指出生胎龄小于37周、出生体重低于2500 g的新生儿,是需要特殊关注的群体,合理的营养支持是提高其存活率的关键环节之一,不仅关系到近期生长和疾病转归,而且直接影响远期预后,充足均衡的营养是保证早产/低出生体重儿健康成长的物质基础.     

早产/低出生体重儿喂养建议

早产/低出生体重儿是指出生胎龄小于37周、出生体重低于2500 g的新生儿,是需要特殊关注的群体,合理的营养支持是提高其存活率的关键环节之一,不仅关系到近期生长和疾病转归,而且直接影响远期预后,充足均衡的营养是保证早产/低出生体重儿健康成长的物质基础.     

早产/低出生体重儿喂养建议

早产/低出生体重儿是指出生胎龄小于37周、出生体重低于2500 g的新生儿,是需要特殊关注的群体,合理的营养支持是提高其存活率的关键环节之一,不仅关系到近期生长和疾病转归,而且直接影响远期预后,充足均衡的营养是保证早产/低出生体重儿健康成长的物质基础.     

早产/低出生体重儿喂养建议

早产/低出生体重儿是指出生胎龄小于37周、出生体重低于2500 g的新生儿,是需要特殊关注的群体,合理的营养支持是提高其存活率的关键环节之一,不仅关系到近期生长和疾病转归,而且直接影响远期预后,充足均衡的营养是保证早产/低出生体重儿健康成长的物质基础.     

早产/低出生体重儿喂养建议

早产/低出生体重儿是指出生胎龄小于37周、出生体重低于2500 g的新生儿,是需要特殊关注的群体,合理的营养支持是提高其存活率的关键环节之一,不仅关系到近期生长和疾病转归,而且直接影响远期预后,充足均衡的营养是保证早产/低出生体重儿健康成长的物质基础.     

早产/低出生体重儿喂养建议

早产/低出生体重儿是指出生胎龄小于37周、出生体重低于2500 g的新生儿,是需要特殊关注的群体,合理的营养支持是提高其存活率的关键环节之一,不仅关系到近期生长和疾病转归,而且直接影响远期预后,充足均衡的营养是保证早产/低出生体重儿健康成长的物质基础.     

早产/低出生体重儿喂养建议

早产/低出生体重儿是指出生胎龄小于37周、出生体重低于2500 g的新生儿,是需要特殊关注的群体,合理的营养支持是提高其存活率的关键环节之一,不仅关系到近期生长和疾病转归,而且直接影响远期预后,充足均衡的营养是保证早产/低出生体重儿健康成长的物质基础.     

早产/低出生体重儿喂养建议

早产/低出生体重儿是指出生胎龄小于37周、出生体重低于2500 g的新生儿,是需要特殊关注的群体,合理的营养支持是提高其存活率的关键环节之一,不仅关系到近期生长和疾病转归,而且直接影响远期预后,充足均衡的营养是保证早产/低出生体重儿健康成长的物质基础.     

早产/低出生体重儿喂养建议

早产/低出生体重儿是指出生胎龄小于37周、出生体重低于2500 g的新生儿,是需要特殊关注的群体,合理的营养支持是提高其存活率的关键环节之一,不仅关系到近期生长和疾病转归,而且直接影响远期预后,充足均衡的营养是保证早产/低出生体重儿健康成长的物质基础.     

早产/低出生体重儿喂养建议

早产/低出生体重儿是指出生胎龄小于37周、出生体重低于2500 g的新生儿,是需要特殊关注的群体,合理的营养支持是提高其存活率的关键环节之一,不仅关系到近期生长和疾病转归,而且直接影响远期预后,充足均衡的营养是保证早产/低出生体重儿健康成长的物质基础.     

Supraventricular tachycardia in newborn infants and infants

Four types of supraventricular tachycardia were identified in a retrospective study of 71 babies who presented under the age of 3 months. The arrhythmia originated in the atrium in the first two types (25% of cases, atrial tachycardia 10 cases, chaotic atrial tachycardia 7 cases). In the other types the arrhythmia originated at the atrioventricular node. Reciprocal rhythms were most common (62%) and those starting in the bundle of His the least common (5%). It is relatively easy to distinguish the different types which are important because treatment may vary. Overall 75% recover completely, 11% have sporadic recurrences and 10% have a chronic arrhythmia. The junctional varieties have the worst prognosis.     

Exclusively breast-fed healthy infants grow slower than reference infants

We have studied the nutritional adequacy of exclusive breast-feeding by following prospectively the growth and protein nutrition of healthy infants during the 1st yr of life. The number of exclusively breast-fed infants was 116 at the age of 6 months and 36 at 9 months. These infants had slower length velocity after age 3 months than a comparison group of 32 infants who were weaned early and given formula plus solids. As a group, the exclusively breast-fed infants lagged slightly, but progressively, behind in relative length. By 9 months, 45% of them versus 18% of the comparison group showed a greater than 1 SD decrease in relative length. No such decrease was found in relative weight. Skinfolds and weight for length index showed that they were heavier for their length than the comparison infants. At 6 and 9 months the calculated protein intake (0.9 g/kg/day) was much less than the recommended amount (2.0 g/kg/day). Serum prealbumin concentration was lower than in the comparison group but this was noted as early as 4 months. No relation was found between the parameters of growth and protein nutrition either individually or in general. Whether the slower growth of the exclusively breast-fed infants represents appropriate physiological growth or whether it indicates nutritional deficiency is not known but we did not find any evidence of protein deficiency. Six infants did, however, show subsequent catch-up growth which could indicate previous malnutrition.     

Pharmacokinetic study of cefotaxime in newborn infants and infants

The serum kinetics of intravenous cefotaxime was studied in 13 neonates and 5 infants presenting with bacterial infections in order to establish the dosage and route of administration. Average dosage was 66.6 mg/kg/day in neonates and 62 mg/kg/day in infants. Cefotaxime was given intravenously in 3 daily bolus injections in infants and 2 bolus injections in neonates under 8 days of age. In infants the average serum peak was 173 mcg/ml at 15 min. Serum half-life was between 0.45 and 0.50 hr (T 1/2 beta) close to the one found in adults. In neonates the average serum peak was 106.2 mcg/ml at 35 min. Serum half-life was 1.71 hr (T 1/2 beta). It is prolonged in neonates who are younger, more premature and have a lower weight. In full term neonates, during the first 8 days, the desirable dose seems to be 75 to 150 mg/kg/day in 3 injections, according to the severity of the infection. In premature neonates under 8 days of age, the interval between injections should be increased up to 12 hrs. Finally, in full term neonates older than 8 days and in infants, one injection every 6 hours seems to be advisable.